Drug-resistant fungus on the rise in Tennessee: Here’s who’s most at risk

A drug-resistant fungal superbug has been confirmed across 23 states in the United States as of August 2026. According to reports from the-sun.com, this specific fungus is characterized by a mortality rate of 60% and is described as being completely drug-resistant. Recent developments include the confirmation of more cases by Louisiana health officials, while WKRN News 2 reports that the fungus is currently on the rise in Tennessee. Coverage focuses on identifying who is most at risk as the pathogen continues to spread through different regions of the country. Multiple media outlets are tracking the expansion of the superbug.

The-sun.com explicitly links the nature of the fungus to themes seen in 'The Last of Us' due to its severity and drug resistance. Healthline and The Hill are both reporting on the confirmation of the fungus in 23 states, with The Hill specifically questioning the geographic spread of the deadly pathogen in 2026. These outlets emphasize the urgent need for public awareness regarding the drug-resistant nature of the organism and the current state of its distribution. The context of this trend is rooted in the extreme difficulty of treating the infection, as the coverage underscores that the fungus is completely drug-resistant. This lack of effective medical intervention contributes to the reported 60% mortality rate cited by the-sun.com.

The spread to 23 states indicates a broad geographic footprint, moving beyond isolated incidents to a multi-state health concern. The involvement of state-level health officials in Louisiana suggests that government monitoring is active as the case counts increase. Future developments to watch include further updates from health officials in Louisiana and Tennessee regarding case numbers and risk factors. Because WKRN News 2 is highlighting who is most at risk, forthcoming information will likely specify the vulnerable demographics. Monitoring will continue as The Hill and other outlets track whether the fungus spreads beyond the currently confirmed 23 states or if new treatment options are identified to combat the drug-resistant properties of the superbug.